Life ScienceCompany
Bio-Techne has acquired 16 companies, including 8 in the last 5 years. A total of 3 acquisitions came from private equity firms.
Bio-Techne’s largest acquisition to date was in 2021, when it acquired Asuragen for $320M. Bio-Techne has acquired in 8 different US states, and 3 countries. The Company’s most targeted sectors include life science (57%) and medical products (19%).
Join Mergr and gain access to Bio-Techne’s M&A summary, the M&A summaries of companies just like it, as well as recent M&A activity in the life science sector.
M&A Summary
-
M&A Total Activity16
- M&A Buy Activity16
- Total Sectors Invested 6
- Total Countries Invested 3
- M&A Buy/Sell Connections 3
- M&A Advisors 1
Unlimited Searches
